Related Experiment Videos
Positron emission tomography and interventional cardiology
1Division of Cardiology, University of Texas Medical School, Houston 77225.
Insights
Cardiac positron emission tomography (PET) offers highly accurate, noninvasive diagnosis for coronary artery disease (CAD). This advanced imaging can guide treatment decisions for both symptomatic and asymptomatic patients, improving patient outcomes.
Area of Science:
- Cardiovascular imaging
- Nuclear cardiology
- Diagnostic medicine
Background:
- Current noninvasive diagnostic methods for coronary artery disease (CAD) lack sufficient accuracy, especially in asymptomatic individuals.
- Existing techniques fail to reliably assess stenosis severity, coronary artery involvement, collateral circulation, and myocardial viability.
Purpose of the Study:
- To evaluate the diagnostic utility of cardiac positron emission tomography (PET) for coronary artery disease (CAD).
- To assess PET's capability in determining stenosis severity, guiding interventions, and imaging myocardial pathophysiology.
Main Methods:
- Cardiac PET imaging utilizing rubidium-82, N-13 ammonia, or F-18 deoxyglucose.
- Analysis based on over 1,000 cardiac studies conducted at the University of Texas.
- Comparison with automated quantitative coronary arteriography for stenosis assessment.
Main Results:
- Cardiac PET demonstrated high sensitivity (95-98%) and specificity (95-100%) for diagnosing CAD in symptomatic and asymptomatic patients.
- PET scan accuracy is sufficient to guide decisions for diagnostic catheterization and revascularization procedures.
- PET effectively assesses stenosis severity, monitors intervention effectiveness, and images myocardial infarction, ischemia, and viability.
Conclusions:
- Cardiac PET is a highly accurate noninvasive tool for diagnosing coronary artery disease (CAD).
- PET imaging enables precise patient stratification for targeted therapies, including cholesterol-lowering treatments and percutaneous transluminal coronary angioplasty (PTCA).
- PET provides comprehensive information on myocardial status, aiding in the management of ischemic heart disease.
Abstract:
Current noninvasive diagnostic techniques have limited accuracy for detection of coronary artery disease (CAD) in symptomatic and (particularly) asymptomatic patients with silent disease. Furthermore, no standard noninvasive method provides reliable diagnostic information on the location of the coronary arteries involved, the severity of stenosis, the presence of collaterals and myocardial viability. Based on greater than 1,000 cardiac studies at the University of Texas, cardiac positron emission tomography (PET) with either generator-produced rubidium-82, cyclotron-produced N-13 ammonia, or F-18 deoxyglucose is suitable for 4 routine diagnostic purposes: (1) noninvasive diagnosis of CAD in either symptomatic or asymptomatic subjects with a sensitivity of 95 to 98% and specificity of 95 to 100%. This accuracy is now sufficient to schedule diagnostic catheterization and multivessel angioplasty with surgical backup on the basis of the PET scan. At the University of Texas we carry out PET in asymptomatic and symptomatic patients to direct those with mild disease to cholesterol-lowering reversal therapy and those with severe disease to percutaneous transluminal coronary angioplasty (PTCA); (2) assessment of physiologic severity of coronary artery stenosis as compared to automated quantitative coronary arteriographic analysis. Changes in stenosis severity are followed before and after interventions including PTCA, bypass surgery, vasodilator drugs and cholesterol control regimens for reversal of coronary atherosclerosis; (3) imaging myocardial infarction, ischemia, viability, zone at risk and sizing of these pathophysiologic processes.(ABSTRACT TRUNCATED AT 250 WORDS)